(MedPage Today) — ORLANDO — An orally disintegrating tablet form of sebetralstat (Ekterly) for young children with hereditary angioedema (HAE) showed similar results as the non-disintegrating tablet used in adults, a phase III trial indicated…
Source link : https://www.medpagetoday.com/meetingcoverage/acaai/118411
Author :
Publish date : 2025-11-10 15:54:00
Copyright for syndicated content belongs to the linked Source.






